Regarding the rs2331291 TT genotype group (n = 11), Table 9 demonstrates that the serum MIAT level was not significantly higher in hypertensive CIS patients compared to non-hypertensive CIS patients (0.61 ± 0.51; vs. 0.39 ± 0.17; mean ± SD). The gene discussed is MIAT; the disease is in situ carcinoma.